Amebic Encephalitis in a Patient with Chronic Lymphocytic Leukemia on Ibrutinib Therapy

Chronic lymphocytic leukemia (CLL) is the most common type of leukemia in Western countries. A common first-line therapy offered to qualifying patients includes ibrutinib, an oral covalent inhibitor of Bruton's tyrosine kinase. Treatment of CLL with ibrutinib therapy is generally well tolerated...

Descripción completa

Detalles Bibliográficos
Autores principales: Voshtina, Ensi, Huang, Huiya, Raj, Renju, Atallah, Ehab
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6092972/
https://www.ncbi.nlm.nih.gov/pubmed/30155323
http://dx.doi.org/10.1155/2018/6514604

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6092972/
https://www.ncbi.nlm.nih.gov/pubmed/30155323
http://dx.doi.org/10.1155/2018/6514604

Ejemplares similares